Feb 26 2026 - Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results...
Feb 17 2026 - Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results...
Jan 9 2026 - Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net...
Dec 4 2025 - Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable...
Thank you for submitting your request. A Heron Therapeutics representative will be in contact.
Instructions: This form is intended for use by trained CrossLink representatives regarding questions from US Medical Professionals only. Fields marked with an asterisk (*) are mandatory.
Unsolicited Medical Information Request for ZYNRELEF® (bupivacaine and meloxicam) extended-release solution
A signature will not be collected on this form.